Neola Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Net Income	-11.02	-10.06	-9.01	-10.35	-6.65	Upgrade
Depreciation & Amortization	1.39	1.39	1.43	0.57	0.02	Upgrade
Other Amortization	-	0.12	0.16	0.2	-	Upgrade
Asset Writedown & Restructuring Costs	-	-	-	0.27	-	Upgrade
Other Operating Activities	-1.04	0.09	0.24	0.06	0.01	Upgrade
Change in Accounts Receivable	-	0.04	-0.02	0.33	-1.07	Upgrade
Change in Accounts Payable	-	-1.11	0.69	0.16	0.34	Upgrade
Change in Other Net Operating Assets	-1.28	-1.24	-0.03	0.27	0.43	Upgrade
Operating Cash Flow	-11.95	-10.77	-6.54	-8.5	-6.93	Upgrade
Capital Expenditures	-	-0.15	-	-0.1	-0.17	Upgrade
Sale (Purchase) of Intangibles	-9.34	-11.04	-12.31	-11.45	-10.35	Upgrade
Investing Cash Flow	-9.34	-11.18	-12.31	-11.56	-10.52	Upgrade
Issuance of Common Stock	19.5	20	-	43.95	23.74	Upgrade
Other Financing Activities	-1.64	-0.07	0.34	-6.75	-	Upgrade
Financing Cash Flow	17.86	19.93	0.34	37.2	23.74	Upgrade
Net Cash Flow	-3.43	-2.02	-18.51	17.15	6.29	Upgrade
Free Cash Flow	-11.95	-10.92	-6.54	-8.6	-7.1	Upgrade
Free Cash Flow Margin	-144.30%	-107.90%	-66.59%	-88.27%	-63.83%	Upgrade
Free Cash Flow Per Share	-0.16	-0.16	-0.12	-0.33	-0.51	Upgrade
Cash Income Tax Paid	-	-	-0.02	-0.03	0.01	Upgrade
Levered Free Cash Flow	-16.17	2.12	-35.93	-14.63	-14.95	Upgrade
Unlevered Free Cash Flow	-16.17	2.12	-35.93	-14.63	-14.95	Upgrade
Change in Working Capital	-1.28	-2.31	0.64	0.76	-0.3	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.